AzTrials
AzTrials

Multiple SclerosisNCT05326711

Effects of Telerehabilitation-Based Motor Imagery Training on Pain in People With Multiple Sclerosis

A study testing Telerehabilitation-based motor imagery training in people with Multiple Sclerosis and Pain, run by Dokuz Eylul University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this studly, the effects of an 8-week telerehabilitation-based motor imagery training on pain and related factors in persons with multiple sclerosis will be investigated. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Multiple Sclerosis, Pain
What is being tested?
Telerehabilitation-based motor imagery training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
2 sitesTurkey (Türkiye)
Study dates
11 Apr 2022to 21 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Having been diagnosed with MS according to McDonald diagnostic criteria
  • Not having an attack in the last 3 months.
  • To have sufficient smartphone/tablet or computer knowledge to participate in the study or to have a relative who can help in this regard.
  • Having an active internet connection at home.
  • Having a smart phone/tablet or computer suitable for videoconferencing.
  • Having a smartphone or tablet.
Show all 10Show fewer
  • Having a pain level of at least 30 mm on the 100 mm visual analog scale (VAS) for at least 3 months in at least one of the hand/wrist, foot/ankle, knee, shoulder, neck and back regions.
  • No change in medications used for pain in the last 2 months.
  • Not receiving additional treatment other than routine treatments.
  • To be able to read and understand Turkish.

Who cannot join

  • Pregnancy
  • Having a musculoskeletal, cardiovascular, pulmonary, metabolic, or other disease severe enough to preclude participation in the study.
  • Presence of conditions other than MS that can cause pain, such as cancer, diabetes, overt osteoarthritis, or rheumatoid arthritis based on laboratory or imaging findings
  • Having a psychiatric illness.
  • Presence of severe cognitive impairment detected by the physician at a level that prevents the tests from being performed
  • Having severe vision and hearing problems.

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Dokuz Eylul University Hospital, MS Outpatient Clinic

    Izmir, Inciralti, 35340

  • Dokuz Eylul University Hospital, MS Outpatient Clinic

    Izmir, 35430

Other trials in Turkey (Türkiye)

About this study

In this studly, the effects of an 8-week telerehabilitation-based motor imagery training on pain and related factors in persons with multiple sclerosis will be investigated.

Read the detailed description

Multiple sclerosis (MS) is a chronic, progressive, and demyelinating disease of the central nervous system that affects more than 2.5 million people worldwide and is more common in young adults. The most common clinical signs and symptoms include motor dysfunction, fatigue, spasticity, cognitive impairment, depression, decreased quality of life, bladder and bowel dysfunction and pain. People with Multiple Sclerosis (pwMS) show a wide range of pain symptoms, from acute pain symptoms to chronic pain symptoms. Pain is an important symptom in pwMS and is often associated with disability. Pain is a fairly common symptom in pwMS. The prevalence of pain in MS was found to be 63%. In addition, 30% of pwMS describe pain as their most severe symptom.

In the studies, it was found that motor imagery training, which is defined as imagining movement without revealing the movement in reality, is a training at the cortical level and reduces pain by creating positive effects on the impaired body schema perception. However, the effect of motor imagery training on pain in pwMS has not been investigated before.

For this reason, the aim of this study is to investigate the effect of telerehabilitation-based motor imagery training protocol, guidance of a physiotherapist, on pain, fatigue, anxiety, depression, quality of life and sleep quality in pwMS.

Persons who followed by the outpatient Multiple Sclerosis Clinic of Dokuz Eylül University Hospital will participate in the study. A total of 32 participants will randomly be divided into 2 groups. (1) Telerehabilitation-based motor imagery training, (2) Control group. Telerehabilitation-based motor imagery training group will individually receive telerehabilitation-based motor imagery training under the guidance of a physiotherapist for 8 weeks.

The first 2 weeks of the treatment period, will reserved for implicit motor imagery / lateralization training. It will be performed by the "noi group application" application that can be downloaded to the participants' mobile devices (smartphone or tablet). Lateralization training will be aimed at the initially evaluated areas of the participants (neck, back, shoulder, knee, hand/wrist, foot/ankle) that have a pain level of at least 30 mm according to the Visual Pain Scale (VAS). In the application, the participants will be asked to discriminant right and left with simple photographs of the painful areas determined at the beginning, and more complex photographs will be used as the training progresses. Participants will be asked to use the app 3 times a day. In each application session, the right / left discrimination of the region in the photograph will be requested within 5 seconds and 30 photographs will be shown for each painful region. Each session will last 2-3 minutes on average, depending on the number of painful areas of the participants. Controls will be made over the results sent to the e-mail address of the physiotherapist through the application. For 3rd to 8th weeks of the treatment period telehabilitation-based motor imagery training will be given to the participants individually, in synchronization, using the Google Meet videoconference platform, under the guidance of a physiotherapist. Participants will participate the treatment with their smart phones, tablets or computers that have an active internet connection and are suitable for meeting via videoconference. The duration of the sessions will last 20-30 minutes.

The control group will not receive treatment other than their routine treatment, and the patients will be informed that the control group participants will be treated if the participants wish at the end of the study. The assessments will be applied at baseline, 8, and 12 weeks.

Being tested
Telerehabilitation-based motor imagery training
Keywords
multiple sclerosis, motor imagery, pain, telerehabilitation
Medical subject headings
Multiple Sclerosis, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telerehabilitation-based motor imagery trainingBehavioural

    Telerehabilitation has been defined as "the delivery of rehabilitation services through information and communication technologies".

Study groups in NCT05326711
Study groupRoleWhat they receive
Telerehabilitation-based motor imagery trainingExperimentalThe first 2 weeks of the treatment period, will reserved for implicit motor imagery / lateralization training. It will be performed by the "noi group application" application that can be downloaded to the participants' mobile devices. Participants will be asked to use the app 3 times a day. In each application session, the right / left discrimination of the region in the photograph will be requested within 5 seconds and 30 photographs will be shown for each painful region. Each session will last 2-3 minutes on average. For 3rd to 8th weeks of the treatment period telehabilitation-based motor imagery training will be given to the participants individually, in synchronization, using the Google Meet videoconference platform, under the guidance of a physiotherapist. The duration of the sessions will last 20-30 minutes.
Receives: Behavioral: Telerehabilitation-based motor imagery training
ControlNo interventionNo specific intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Visual Analog Scale (VAS) Score

    VAS will be used to numerically determine the general pain intensities felt by participants in the last 2 days and the pain intensities of the areas they feel painful on six regions: neck, shoulder, back, hand/wrist, knee, foot/ankle. Participants will be told that 0mm above the 100mm line had "no pain"; It will be stated that 100 mm represents "the most unbearable pain". The degree of pain will be recorded numerically between 0 and 100.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks.

Secondary outcomes (15)
  1. Expanded Disability Status Scale

    Expanded Disability Status Scale is the most frequently used scale in evaluating the disability of pwMS. Scoring based on neurological examination findings takes a value between 0-10. While 0 shows normal neurological findings, 10 means death due to MS. In this scale in which pyramidal, cerebral, cerebellar, visual, sensory, brainstem, bladder and bowel functions are scored, the best performance of the patient without any special effort is evaluated.

    Measured: The assessment will be applied at baseline.

  2. Change in Patient-Determined Disease Steps Scale Score

    Patient-Determined Disease Steps Scale was designed in 1995 as a self-reported outcome measure to enable neurologists without EDSS evaluator certification to measure the level of disability of pwMS. It consists of one question. In PDDS, the patient is asked to choose one of the 9 items that best describes his current walking ability.

    Measured: The assessments will be applied at baseline and 8 weeks.

  3. Change in Numeric Rating Scale Score

    Numeric Rating Scale will be used to determine pain levels in functional activities of participants. Participants are asked to name the number representing the amount of pain, where 0 is "no pain" and 10 is "most unbearable pain". Participants will be asked to identify the 5 activities they find most difficult to do because of their pain and to evaluate their pain for activities.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  4. Change in PainDETECT Questionnaire Score

    PainDETECT Questionnaire is used to determine neuropathic pain of participants. The questionnaire assesses the typical symptoms, signs, and extent of pain of neuropathic pain. A questionnaire score of ≥19 indicates probable neuropathic pain, a score of 13 to 18 indicates that the result is uncertain, and neuropathic pain of ≤12 is unlikely.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  5. Change in Nordic Musculoskeletal Questionnaire Score

    Nordic Musculoskeletal Questionnaire is used to determine the musculoskeletal system pain of participants. Questionnaire; whether there is pain on a figure showing the nine regions anatomically: neck, shoulder, back, elbow, hand/wrist, waist, hip/thigh, knee, foot/ankle, whether you have experienced pain in the last week or one year. questions whether the pain affects work/home life. The form consists of three parts and provides descriptive information about whether the participants have experienced various musculoskeletal pain in the last year and in the last seven days, and whether these pains affect their work/home life. The classical evaluation method is in the form of calculating the response distribution ratios and obtaining descriptive data.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  6. Change in Kinesthetic and Visual Imagery Questionnaire- 20 Score

    Kinesthetic and Visual Imagery Questionnaire- 20 is used to determine the motor imagery skills of participants. The questionnaire consists of a total of 10 movements measuring 5 visual and 5 kinesthetic visualization skills developed to determine the extent to which individuals visualize and feel the imagined movements. The participant give a score between 1 and 5, as "1 point: no image, 5 points: as clear as the original" for the image in the imagery. At the end of the questionnaire, visual imagery score, kinesthetic imagery score and total score are calculated.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks.

  7. Change in Modified Fatigue Impact Scale Score

    Modified Fatigue Impact Scale is used to determine the fatigue level of participants. The questionnaire consists of a total of 21 questions evaluating the physical, cognitive and psychosocial effects of fatigue. Each item is given a score of 0-4. Low score indicates a low degree of fatigue

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  8. Change in Multiple Sclerosis İnternational Quality of Life Questionnaire Score

    Multiple Sclerosis İnternational Quality of Life Questionnaire is used to determine the quality of life of participants. The questionnaire is a self-filled 31-item scale measuring health-related quality of life. The questionnaire questions quality of life in various areas, including activities of daily living, psychological well-being, symptoms, relationships with friends, relationships with family, health care team satisfaction, emotional life and sex life, coping and rejection. The total score is between 0 and 100, and high scores indicate high quality of life perception

    Measured: The assessments will be applied at baseline, 8, and 12 weeks.

  9. Change in Pittsburgh Sleep Quality Index Score

    Pittsburgh Sleep Quality Index is used to determine the sleep quality of participants. The questionnaire includes 24 questions evaluating the sleep quality of the participants for the last month. 19 of these are self-report questions and are answered by the participants themself. Five questions are answered by the participant's spouse or roommate and are used for clinical information only, not included in scoring. The total score takes a value between 0 and 21. Sleep quality of those with a total score of 5 or less was "good"; Those with a score above 5 are considered to have "poor" sleep quality.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks.

  10. Change in Epworth Sleepiness Scale Score

    Epworth Sleepiness Scale is used to determine the daytime sleepiness of participants. The scale consists of 8 items. The score of each item varies between 0-3 and the total score varies between 0-24. High scores indicate high daytime sleepiness

    Measured: The assessments will be applied at baseline, 8, and 12 weeks.

  11. Change in Hospital Anxiety and Depression Scale (HADS) Score

    HADS is used to determine the risk of anxiety and depression in the participants and to measure its level and severity. It is a self-report scale consisting of 7 anxiety and 7 depression related questions in total and two subscales. Items are scored with a 3-level Likert-type scale. High scores indicates high anxiety and depression level.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  12. Change in Mental Chronometer Time Ratio for Timed Up and Go Test Score

    Mental Chronometer Time measurement will be performed with the Timed Up and Go Test. During the Timed Up and Go Test, the participants will be asked to get up from a chair, walk three meters, turn around the board at the end of 3 meters, walk back to the chair and sit. After imagining the movement during the test, participants will actually apply the test. The temporal coherence between real and imagined motion will be calculated in terms of delta time with the formula "(real motion-imagined motion)/[(actual motion + imagined motion)/2] x 100". The duration of actual and imagined movements will be recorded with an electronic stopwatch. The time during the actual movement will be recorded by the physiotherapist. The imaginary time will be recorded by the participants. The participants will start the stopwatch when they started to move the imagined movement and will stop it when the participants completed the imagined movement. Closer scores to 100 mean better temporal coherence.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  13. Change in California Verbal Learning Test-II Score

    The California Verbal Learning Test-II is used to assess verbal memory. Higher scores indicate better verbal memory.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  14. Change in Revised Brief Visuospatial Memory Test Score

    The Revised Brief Visuospatial Memory Test is used to assess visuospatial memory. Higher scores indicate better visuospatial memory.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

  15. Change in Symbol Digit Modalities Test Test Score

    The Symbol Digit Modalities Test is used to assess information processing speed. Using a reference key, the test taker has 90 seconds to pair specific numbers with given geometric figures in the Symbol Digit Modalities Test. The correct matches are calculated as the test score. Higher scores indicate better information processing speed.

    Measured: The assessments will be applied at baseline, 8, and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2022
  2. Study start11 Apr 2022
  3. Primary completion21 Nov 2022
  4. Study completion21 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05326711
Sponsor's protocol ID
2021/29-24
Status last verified
Jul 2023
First submitted
16 Nov 2021
Last updated
11 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Telerehabilitation-based motor imagery training in people with Multiple Sclerosis and Pain, run by Dokuz Eylul University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Visual Analog Scale (VAS) Score (time frame: The assessments will be applied at baseline, 8, and 12 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in